When you purchase products or services through our links we and our partners earn a small commission. Thank you.
Abortion pill ruling opens door to more political pressure on medical regulators
The country is closely watching how the battle over abortion medication unfolds in federal courts. It follows a Texas judge’s decision to overturn FDA approval of the mifepristone. But there’s also growing concern over what that ruling could mean for the drug approval process in general. Amna Nawaz discussed what's at stake with Dr. Joshua Sharfstein, the former FDA principal deputy commissioner.
Leave A Comment
MORE LIKE THIS
Special Offers From Our Affiliates